[HTML][HTML] CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-cell-dependent manner
RM Mbofung - Oncogene, 2017 - nature.com
Combining immunotherapy with targeted therapy has increasingly become an appealing
therapeutic paradigm for cancer treatment due to its great potential for generating durable …
therapeutic paradigm for cancer treatment due to its great potential for generating durable …
CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-cell-dependent manner.
L Huang, Z Wang, C Liu, C Xu, RM Mbofung… - Oncogene, 2017 - europepmc.org
Combining immunotherapy with targeted therapy has increasingly become an appealing
therapeutic paradigm for cancer treatment due to its great potential for generating durable …
therapeutic paradigm for cancer treatment due to its great potential for generating durable …
CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-cell-dependent manner
L Huang, Z Wang, C Liu, C Xu… - …, 2017 - mdanderson.elsevierpure.com
Combining immunotherapy with targeted therapy has increasingly become an appealing
therapeutic paradigm for cancer treatment due to its great potential for generating durable …
therapeutic paradigm for cancer treatment due to its great potential for generating durable …
CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-cell-dependent manner
L Huang, Z Wang, C Liu, C Xu, RM Mbofung… - …, 2017 - pubmed.ncbi.nlm.nih.gov
Combining immunotherapy with targeted therapy has increasingly become an appealing
therapeutic paradigm for cancer treatment due to its great potential for generating durable …
therapeutic paradigm for cancer treatment due to its great potential for generating durable …
[HTML][HTML] CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-cell-dependent manner
L Huang, Z Wang, C Liu, C Xu, RM Mbofung… - Oncogene, 2017 - ncbi.nlm.nih.gov
Combining immunotherapy with targeted therapy has increasingly become an appealing
therapeutic paradigm for cancer treatment due to its great potential for generating durable …
therapeutic paradigm for cancer treatment due to its great potential for generating durable …
CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-cell-dependent manner
L Huang, Z Wang, C Liu, C Xu, RM Mbofung… - Oncogene, 2017 - go.gale.com
Combining immunotherapy with targeted therapy has increasingly become an appealing
therapeutic paradigm for cancer treatment due to its great potential for generating durable …
therapeutic paradigm for cancer treatment due to its great potential for generating durable …
[HTML][HTML] CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B cell-dependent manner
L Huang, Z Wang, C Liu, C Xu, R Mbofung… - Oncogene, 2017 - ncbi.nlm.nih.gov
Combining immunotherapy with targeted therapy has increasingly become an appealing
therapeutic paradigm for cancer treatment due to its great potential for generating durable …
therapeutic paradigm for cancer treatment due to its great potential for generating durable …
[引用][C] CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-cell-dependent manner.
L Huang, Z Wang, C Liu, C Xu, RM Mbofung… - Oncogene, 2017 - europepmc.org